CAROLINE CUNNINGHAM: Open Payments
NPI 1144052028 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,239 in 197 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $273 · 2025 $4,239
Food & beverage: $4,109Education: $129
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $466 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 16 | $454 |
| Insmed, Inc. | 33 | $452 |
| AstraZeneca Pharmaceuticals LP | 13 | $407 |
| Grifols USA, LLC | 13 | $381 |
| GlaxoSmithKline, LLC. | 22 | $362 |
| Viatris Specialty LLC | 18 | $295 |
| Actelion Pharmaceuticals US, Inc. | 8 | $265 |
| Merck Sharp & Dohme LLC | 10 | $243 |
| Verona Pharma, Inc. | 15 | $173 |
Products named: DUPIXENT, Arikayce, Prolastin-C Liquid, YUPELRI, AIRSUPRA, UPTRAVI, TRELEGY ELLIPTA, WINREVAIR.
Industry payments across KY — which companies pay providers there.
